Last reviewed · How we verify
A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A
This study is a prospective, multicenter, randomized controlled trial and aims to evaluate efficacy and safety of Xuanfei Baidu Granule in the treatment of influenza A. This study plans to enroll 584 subjects. The subjects will be randomly divided into 4 groups according to the ratio of 1:1:1:1, and they will be treated with Xuanfei Baidu Granule Placebo, Xuanfei Baidu Granule, Xuanfei Baidu Granule combined with Baloxavir Marboxil tablet.1 bag of Xuanfei Baidu Granule and Xuanfei Baidu Granule Placebo in the morning and evening, and take with boiling water for 5 days. Baloxavir Marboxil Tablet was taken orally 2 tablets, once a day for 1 day. The subjects were visited every day for 7 days after enrollment.
Details
| Lead sponsor | Capital Medical University |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 584 |
| Start date | 2024-01 |
| Completion | 2025-01 |
Conditions
- Influenza A
Interventions
- Xuanfei Baidu Granule Placebo
- Xuanfei Baidu Granule
- Baloxavir Marboxil Tablet
Primary outcomes
- The time to fever resolution. — within 7 days of enrollment
Definition of fever resolution: the body temperature drops to ≤37 ℃ and is maintained for more than 24 hours. Definition of time to fever resolution: the time from the first dose to the resolution of fever.
Countries
China